AI Showcase for Drug Development & Advances in Fibrosing Lung Disease
- Learn about the robust clinical data curation, global normalization and advanced data power to drive radical progress in drug development for fibrosing lung diseases
- See quantifiable Artificial Intelligence (AI) advances that this data has already powered, including various disease quantification tools and emerging innovations
- Discuss the long-term vision of imaging in fibrosing lung diseases, including the potential inclusion of lung cancer screening for risk scoring of ILA’s
- Learn about Project Opus, a new, real-time observational study that applies AI and machine learning technology to the spirometry, environmental, and imaging data